123 related articles for article (PubMed ID: 36605447)
21. Comparison of long-term results between radiotherapy after breast-conserving surgery and postmastectomy radiotherapy in stage T1-2N1M0 breast cancer.
Lan XW; Wen G; He Z; Huang JH; Zou XB; Lin X; Tan YT; Huang XB
Cancer Manag Res; 2019; 11():6477-6487. PubMed ID: 31372049
[TBL] [Abstract][Full Text] [Related]
22. [Prognosis and risk factors of 1 791 patients with breast cancer treated with breast-conserving surgery based on real-world data].
Chen SY; Tang Y; Song YW; Wang SL; Jin J; Liu YP; Wang WH; Fang H; Ren H; Sun GY; Wang JY; Jing H; Zhang JH; Liu XF; Yu ZH; Li YX
Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):619-625. PubMed ID: 30139034
[No Abstract] [Full Text] [Related]
23. Trends in Regional Nodal Management of Breast Cancer Patients with Low Nodal Burden.
Raber BM; Lin H; Shen Y; Shaitelman SF; Bedrosian I
Ann Surg Oncol; 2019 Dec; 26(13):4346-4354. PubMed ID: 31605340
[TBL] [Abstract][Full Text] [Related]
24. Prognosis and Prophylactic Regional Nodal Irradiation in Breast Cancer Patients With the First Isolated Chest Wall Recurrence After Mastectomy.
Zhao XR; Xuan L; Yin J; Tang Y; Sun HR; Jing H; Song YW; Jin J; Liu YP; Fang H; Ren H; Chen B; Tang Y; Li N; Qi SN; Lu NN; Yang Y; Li YX; Sun B; Wu SK; Wang SL
Front Oncol; 2020; 10():600525. PubMed ID: 33643906
[TBL] [Abstract][Full Text] [Related]
25. The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy.
Vicini FA; Horwitz EM; Lacerna MD; Brown DM; White J; Dmuchowski CF; Kini VR; Martinez A
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1069-76. PubMed ID: 9392546
[TBL] [Abstract][Full Text] [Related]
26. Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
Jwa E; Shin KH; Lim HW; Jung SY; Lee S; Kang HS; Lee E; Park YH
PLoS One; 2015; 10(12):e0145463. PubMed ID: 26691445
[TBL] [Abstract][Full Text] [Related]
27. Incorporating Risk Factors to Identify the Indication of Post-mastectomy Radiotherapy in N1 Breast Cancer Treated with Optimal Systemic Therapy: A Multicenter Analysis in Korea (KROG 14-23).
Park HJ; Shin KH; Kim JH; Ahn SD; Kim JY; Park W; Kim YB; Kim YJ; Kim JH; Kim K; Park KR; Shin HS; Jeong BK; Lee SY; Kim S
Cancer Res Treat; 2017 Jul; 49(3):739-747. PubMed ID: 27764904
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of the AJCC 8th edition staging system for selecting patients with T1-2N1 breast cancer for post-mastectomy radiotherapy: a joint analysis of 1986 patients from two institutions.
Wang S; Wen G; Tang Y; Yang Y; Jing H; Wang J; Zhang J; Zhao X; Sun G; Jin J; Song Y; Liu Y; Fang H; Zhang Y; Li Y
BMC Cancer; 2020 Aug; 20(1):792. PubMed ID: 32838753
[TBL] [Abstract][Full Text] [Related]
29. The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.
Rusthoven CG; Rabinovitch RA; Jones BL; Koshy M; Amini A; Yeh N; Jackson MW; Fisher CM
Ann Oncol; 2016 May; 27(5):818-27. PubMed ID: 26861597
[TBL] [Abstract][Full Text] [Related]
30. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
Truong PT; Jones SO; Kader HA; Wai ES; Speers CH; Alexander AS; Olivotto IA
Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):357-64. PubMed ID: 18676091
[TBL] [Abstract][Full Text] [Related]
31. Practical Model to Optimize the Strategy of Adjuvant Postmastectomy Radiotherapy in T1-2N1 Breast Cancer With Modern Systemic Therapy.
Xu FF; Cao L; Xu C; Cai G; Wang SB; Qi WX; Chen JY
Front Oncol; 2022; 12():789198. PubMed ID: 35280719
[TBL] [Abstract][Full Text] [Related]
32. Patient-reported acute fatigue in elderly breast cancer patients treated with and without regional nodal radiation.
Misra S; Lee G; Korzets Y; Wang L; Lau A; Koch CA; Croke J; Helou J
Breast Cancer Res Treat; 2020 Sep; 183(2):391-401. PubMed ID: 32651754
[TBL] [Abstract][Full Text] [Related]
33. Postoperative Radiotherapy Contributes to the Survival Benefit of Breast-Conserving Therapy over Mastectomy.
Chen CY; Zheng SY; Cai G; Xu C; Cai R; Li M; Shen KW; Chen XS; Ou D; Qi WX; Cao L; Chen JY
J Oncol; 2022; 2022():4145872. PubMed ID: 36618070
[TBL] [Abstract][Full Text] [Related]
34. Regional nodal irradiation (RNI) in breast cancer patients with residual isolated tumor cells or micrometastatic nodal disease after neoadjuvant chemotherapy.
Kim JK; Karp JM; Gerber NK
Clin Transl Radiat Oncol; 2023 Jan; 38():195-201. PubMed ID: 36479237
[TBL] [Abstract][Full Text] [Related]
35. Axillary lymph node dissection can be omitted in patients with limited clinically node-positive breast cancer: a National Cancer Database analysis.
Cocco D; Shah C; Wei W; Wilkerson A; Grobmyer SR; Al-Hilli Z
Br J Surg; 2022 Nov; 109(12):1293-1299. PubMed ID: 36066266
[TBL] [Abstract][Full Text] [Related]
36. Impact of Oncotype DX Recurrence Score on the Patterns of Locoregional Recurrence in Breast Cancer (Korean Radiation Oncology Group 19-06).
Kim K; Jung J; Shin KH; Kim JH; Chang JH; Kim SS; Kim H; Park W; Kim YB; Chang JS
J Breast Cancer; 2020 Jun; 23(3):314-319. PubMed ID: 32595993
[TBL] [Abstract][Full Text] [Related]
37. Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated.
Leonardi MC; Scognamiglio IR; Maisonneuve P; Dicuonzo S; Rojas DP; Zerella MA; Morra A; Gerardi MA; Zaffaroni M; De Scalzi A; Girardi A; Magnoni F; Montagna E; Fodor CI; Galimberti VE; Veronesi P; Orecchia R; Pacelli R; Jereczek-Fossa BA; Corso G
Breast Cancer Res Treat; 2021 Jul; 188(2):511-524. PubMed ID: 33905020
[TBL] [Abstract][Full Text] [Related]
38. Clinical Effectiveness of an Adaptive Treatment Planning Algorithm for Intensity Modulated Radiation Therapy Versus 3D Conformal Radiation Therapy for Node-Positive Breast Cancer Patients Undergoing Regional Nodal Irradiation/Postmastectomy Radiation Therapy.
Bazan JG; Healy E; Beyer S; Kuhn K; DiCostanzo D; Smith TL; Jhawar S; White JR
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1159-1171. PubMed ID: 32711036
[TBL] [Abstract][Full Text] [Related]
39. Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?
Cosar R; Uzal C; Tokatli F; Denizli B; Saynak M; Turan N; Uzunoglu S; Ozen A; Sezer A; Ibis K; Uregen B; Yurut-Caloglu V; Kocak Z
Radiat Oncol; 2011 Mar; 6():28. PubMed ID: 21450076
[TBL] [Abstract][Full Text] [Related]
40. The optimal regional irradiation volume for breast cancer patients: A comprehensive systematic review and network meta-analysis of published studies.
Qi WX; Cao L; Xu C; Cai G; Chen J
Front Oncol; 2023; 13():1081201. PubMed ID: 36798812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
